Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis.
Marin-Valencia I, Roe CR, Pascual JM.
Mol Genet Metab. 2010 Sep;101(1):9-17. doi: 10.1016/j.ymgme.2010.05.004. Epub 2010 Jun 9. Review.
Related citations
Structural insights on pathogenic effects of novel mutations causing pyruvate carboxylase deficiency.
Monnot S, Serre V, Chadefaux-Vekemans B, Aupetit J, Romano S, De Lonlay P, Rival JM, Munnich A, Steffann J, Bonnefont JP.
Hum Mutat. 2009 May;30(5):734-40. doi: 10.1002/humu.20908.
The molecular basis of pyruvate carboxylase deficiency: mosaicism correlates with prolonged survival.
Wang D, Yang H, De Braganca KC, Lu J, Yu Shih L, Briones P, Lang T, De Vivo DC.
Mol Genet Metab. 2008 Sep-Oct;95(1-2):31-8. doi: 10.1016/j.ymgme.2008.06.006. Epub 2008 Aug 3.
A case of pyruvate carboxylase deficiency with atypical clinical and neuroradiological presentation.
Schiff M, Levrat V, Acquaviva C, Vianey-Saban C, Rolland MO, Guffon N.
Mol Genet Metab. 2006 Feb;87(2):175-7. Epub 2005 Dec 1.
Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects.
García-Cazorla A, Rabier D, Touati G, Chadefaux-Vekemans B, Marsac C, de Lonlay P, Saudubray JM.
Ann Neurol. 2006 Jan;59(1):121-7.
Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy.
Mochel F, DeLonlay P, Touati G, Brunengraber H, Kinman RP, Rabier D, Roe CR, Saudubray JM.
Mol Genet Metab. 2005 Apr;84(4):305-12.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on